Previous 10 | Next 10 |
SEATTLE and VANCOUVER, BC , Sept. 10, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that cytisinicline data w...
SEATTLE and VANCOUVER, BC , Sept. 3, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that it will present at ...
Achieve Life Sciences, Inc. (ACHV) Q2 2020 Earnings Conference Call August 6, 2020 16:30 ET Company Participants Jaime Xinos - Executive Vice President of Commercial Richard Stewart - Chief Executive Officer Cindy Jacobs - Executive Vice President & Chief Medical Officer Jo...
Achieve Life Sciences (NASDAQ: ACHV ) : Q2 GAAP EPS of -$1.68 beats by $0.79 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
SEATTLE and VANCOUVER, British Columbia , Aug. 6, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today ...
Achieve Life Sciences (NASDAQ: ACHV ) down ~7% premarket, after pricing its previously announced public offering of ~476k shares at $10.50/share, discount of ~10% of last close of $11.72. More news on: Achieve Life Sciences, Inc., Stocks on the move, Healthcare stocks news,...
SEATTLE and VANCOUVER, BC , Aug. 4, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced t...
SEATTLE and VANCOUVER, BC, Aug. 3, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced a...
Gainers: Marathon Patent (NASDAQ: MARA ) +107% . More news on: Marathon Patent Group, Inc., Datasea Inc., ADT Inc., Stocks on the move, , Read more ...
Achieve Life Sciences (NASDAQ: ACHV ) receives U.S. patent for its novel analogs of cytisinicline for use in prevention or treatment of CNS and addictive disorders. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Achieve Life Sciences Inc. Company Name:
ACHV Stock Symbol:
NASDAQ Market:
Achieve Life Sciences Inc. Website:
2024-06-07 14:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SEATTLE and VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), or Achieve, a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today ann...
2024-05-27 04:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...